117 related articles for article (PubMed ID: 34790906)
1. Optimal biomechanical parameters for measuring sclerotic chronic graft-versus-host disease.
Baker LX; Chen F; Cronin A; Chen H; Vain A; Jagasia M; Tkaczyk ER
JID Innov; 2021 Sep; 1(3):. PubMed ID: 34790906
[TBL] [Abstract][Full Text] [Related]
2. Interrater reproducibility of the Myoton and durometer devices to quantify sclerotic chronic graft-versus-host disease.
Ghosh S; Baker L; Chen F; Khera Z; Vain A; Zhang K; Hood A; Smith H; Chen H; Jagasia M; Tkaczyk E
Arch Dermatol Res; 2023 Nov; 315(9):2545-2554. PubMed ID: 37227518
[TBL] [Abstract][Full Text] [Related]
3. Identification of Fibroinflammatory and Fibrotic Transcriptomic Subsets of Human Cutaneous Sclerotic Chronic Graft-Versus-Host Disease.
Rosenstein RK; Rose JJ; Brooks SR; Tsai WL; Gadina M; Pavletic SZ; Nagao K; Cowen EW
JID Innov; 2024 Mar; 4(2):100246. PubMed ID: 38357212
[TBL] [Abstract][Full Text] [Related]
4. Biomarker Panel for Chronic Graft-Versus-Host Disease.
Yu J; Storer BE; Kushekhar K; Abu Zaid M; Zhang Q; Gafken PR; Ogata Y; Martin PJ; Flowers ME; Hansen JA; Arora M; Cutler C; Jagasia M; Pidala J; Hamilton BK; Chen GL; Pusic I; Lee SJ; Paczesny S
J Clin Oncol; 2016 Aug; 34(22):2583-90. PubMed ID: 27217465
[TBL] [Abstract][Full Text] [Related]
5. CD19+CD21low B cells and CD4+CD45RA+CD31+ T cells correlate with first diagnosis of chronic graft-versus-host disease.
Greinix HT; Kuzmina Z; Weigl R; Körmoczi U; Rottal A; Wolff D; Kralj M; Kalhs P; Mitterbauer M; Rabitsch W; Edinger M; Holler E; Pickl WF
Biol Blood Marrow Transplant; 2015 Feb; 21(2):250-8. PubMed ID: 25460358
[TBL] [Abstract][Full Text] [Related]
6. Histologic and clinical cross-sectional study of chronic hair loss in patients with cutaneous chronic graft-versus-host disease.
Marks DH; Naftulin JS; Penzi LR; Manatis-Lornell A; Yasuda MR; Chapman CM; Rao SR; Saavedra A; Senna MM
J Am Acad Dermatol; 2019 Nov; 81(5):1134-1141. PubMed ID: 31454500
[TBL] [Abstract][Full Text] [Related]
7. Localization of sclerotic-type chronic graft-vs-host disease to sites of skin injury: potential insight into the mechanism of isomorphic and isotopic responses.
Martires KJ; Baird K; Citrin DE; Hakim FT; Pavletic SZ; Cowen EW
Arch Dermatol; 2011 Sep; 147(9):1081-6. PubMed ID: 21931046
[TBL] [Abstract][Full Text] [Related]
8. Magnetic resonance imaging in sclerotic-type chronic graft-vs-host disease.
Clark J; Yao L; Pavletic SZ; Krumlauf M; Mitchell S; Turner ML; Cowen EW
Arch Dermatol; 2009 Aug; 145(8):918-22. PubMed ID: 19687424
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology and Treatment of Chronic Graft-versus-Host Disease Post-Allogeneic Hematopoietic Cell Transplantation: A US Claims Analysis.
Bachier CR; Aggarwal SK; Hennegan K; Milgroom A; Francis K; Dehipawala S; Rotta M
Transplant Cell Ther; 2021 Jun; 27(6):504.e1-504.e6. PubMed ID: 34158154
[TBL] [Abstract][Full Text] [Related]
10. The concurrent administration of imatinib with extracorporeal photopheresis leads to complete and durable responses in patients with refractory sclerotic type chronic graft-versus-host disease.
Alsuliman T; Magro L; Coiteux V; Gauthier J; Srour M; Lionet A; Beauvais D; Yakoub-Agha I
Curr Res Transl Med; 2020 Apr; 68(2):71-76. PubMed ID: 31631014
[TBL] [Abstract][Full Text] [Related]
11. The Anatomic Distribution of Skin Involvement in Patients with Incident Chronic Graft-versus-Host Disease.
Gandelman JS; Zic J; Dewan AK; Lee SJ; Flowers M; Cutler C; Pidala J; Chen H; Jagasia MH; Tkaczyk ER
Biol Blood Marrow Transplant; 2019 Feb; 25(2):279-286. PubMed ID: 30219700
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive B Cell Phenotyping Profile for Chronic Graft-versus-Host Disease Diagnosis.
Rozmus J; Kariminia A; Abdossamadi S; Storer BE; Martin PJ; Lee SJ; Wolff D; Arora M; Cutler C; Schultz KR
Biol Blood Marrow Transplant; 2019 Mar; 25(3):451-458. PubMed ID: 30447393
[TBL] [Abstract][Full Text] [Related]
13. Skin ulcers related to chronic graft-versus-host disease: clinical findings and associated morbidity.
Jachiet M; de Masson A; Peffault de Latour R; Rybojad M; Robin M; Bourhis JH; Xhaard A; Dhedin N; Sicre de Fontbrune F; Suarez F; Barete S; Parquet N; Nguyen S; Ades L; Rubio MT; Wittnebel S; Bagot M; Socié G; Bouaziz JD
Br J Dermatol; 2014 Jul; 171(1):63-8. PubMed ID: 24404963
[TBL] [Abstract][Full Text] [Related]
14. Elevated Galectin-3 Plasma Concentrations in Recipients of Allogeneic Hematopoietic Cell Transplantation.
DeFilipp Z; Navarro-Alvarez N; Li S; Andrews AR; Johnson A; Chen YB; Ho VT; Ritz J; Spitzer TR; Huang CA
Clin Hematol Int; 2019 Dec; 1(4):201-204. PubMed ID: 34595431
[TBL] [Abstract][Full Text] [Related]
15. Healthcare resource utilization and costs among patients with steroid-resistant chronic graft-versus-host disease in the United States: a retrospective claims database analysis.
Yu J; Lal LS; Anderson A; DuCharme M; Parasuraman S; Weisdorf D
Curr Med Res Opin; 2021 May; 37(5):755-759. PubMed ID: 33615925
[TBL] [Abstract][Full Text] [Related]
16. Tear Lipid Metabolites As Potential Diagnostic Biomarkers for Ocular Chronic Graft-Versus-Host Disease.
Ma J; Shen Z; Peng R; Li C; Hu B; Hong J
Transplant Cell Ther; 2021 Mar; 27(3):232.e1-232.e6. PubMed ID: 33781517
[TBL] [Abstract][Full Text] [Related]
17. Evidence-based, Skin-directed Treatments for Cutaneous Chronic Graft-versus-host Disease.
Kim YJ; Lee GH; Kwong BY; Martires KJ
Cureus; 2019 Dec; 11(12):e6462. PubMed ID: 32025391
[TBL] [Abstract][Full Text] [Related]
18. Impact of cGVHD on socioeconomic outcomes in survivors with pediatric hematopoietic stem cell transplant in Japan: a cross-sectional observational study.
Soejima T; Shiohara M; Ishida Y; Inoue M; Hayakawa A; Sato A; Kamibeppu K; Atsuta Y; Yamashita T
Int J Hematol; 2021 Apr; 113(4):566-575. PubMed ID: 33386599
[TBL] [Abstract][Full Text] [Related]
19. Prehematopoietic Stem Cell Transplantation Tear Cytokines as Potential Susceptibility Biomarkers for Ocular Chronic Graft-Versus-Host Disease.
Cocho L; Fernández I; Calonge M; Sainz de la Maza M; Rovira M; Stern ME; Garcia-Vazquez C; Enríquez-de-Salamanca A
Invest Ophthalmol Vis Sci; 2017 Sep; 58(11):4836-4846. PubMed ID: 28973330
[TBL] [Abstract][Full Text] [Related]
20. Interrater and Intrarater Reliability of a Handheld Myotonometer in Measuring Mechanical Properties of the Neck and Orofacial Muscles.
Taş S; Yaşar Ü; Kaynak BA
J Manipulative Physiol Ther; 2021 Jan; 44(1):42-48. PubMed ID: 33248749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
